Home/Filings/4/0001142576-11-000023
4//SEC Filing

Shue Youe Kong 4

Accession 0001142576-11-000023

CIK 0001142576other

Filed

May 16, 8:00 PM ET

Accepted

May 17, 4:51 PM ET

Size

4.6 KB

Accession

0001142576-11-000023

Insider Transaction Report

Form 4
Period: 2011-05-16
Shue Youe Kong
VP, clinical Development
Transactions
  • Other

    Common stock

    2011-05-16$7.71/sh+1,484$11,44193,044 total
Footnotes (1)
  • [F1]Acquired under the Company's employee stock purchase plan on May 16, 2011.

Issuer

OPTIMER PHARMACEUTICALS INC

CIK 0001142576

Entity typeother

Related Parties

1
  • filerCIK 0001380841

Filing Metadata

Form type
4
Filed
May 16, 8:00 PM ET
Accepted
May 17, 4:51 PM ET
Size
4.6 KB